---
title: "Journal Club"
editor: visual
bibliography: bibliography.bibtex
---

![](files/journal.jpg)

# Overview

Each month, the multi-institutional and multi-disciplinary COIG reviews recent articles describing new insights germane to cutaneous oncology.

The following are the archive of the articles covered to date.

# Shiny App

Click [here](https://cutaneousoncology.shinyapps.io/coig_journal_club_timeline/) to visualize an interactive Shiny application of all of the articles covered today. 


# Articles

## 2022 Articles

::: {.callout-note appearance="minimal" collapse="true"}
## January - December 2022

### November

Kim, Sungjune, Evan Wuthrick, Dukagjin Blakaj, Zeynep Eroglu, Claire Verschraegen, Ram Thapa, Matthew Mills, et al. 2022. "Combined Nivolumab and Ipilimumab with or Without Stereotactic Body Radiation Therapy for Advanced Merkel Cell Carcinoma: A Randomised, Open Label, Phase 2 Trial." The Lancet 400 (10357): 1008--19. https://doi.org/10.1016/s0140-6736(22)01659-2.

### October

Gross, Neil D., David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, et al. 2022. "Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma." *New England Journal of Medicine*387 (17): 1557--68. <https://doi.org/10.1056/nejmoa2209813>.

### August

Reijers, Irene L. M., Alexander M. Menzies, Alexander C. J. van Akkooi, Judith M. Versluis, Noëlle M. J. van den Heuvel, Robyn P. M. Saw, Thomas E. Pennington, et al. 2022. "Personalized Response-Directed Surgery and Adjuvant Therapy After Neoadjuvant Ipilimumab and Nivolumab in High-Risk Stage III Melanoma: The PRADO Trial." Nature Medicine 28 (6): 1178--88. https://doi.org/10.1038/s41591-022-01851-x.

### July

Ruiz, Emily S., Kylee J. B. Kus, Timothy D. Smile, Fadi Murad, Guohai Zhou, Evelyn O. Ilori, Jonathan D. Schoenfeld, et al. 2022. "Adjuvant Radiation Following Clear Margin Resection of High T-Stage Cutaneous Squamous Cell Carcinoma Halves the Risk of Local and Locoregional Recurrence: A Dual-Center Retrospective Study." Journal of the American Academy of Dermatology 87 (1): 87--94. https://doi.org/10.1016/j.jaad.2022.03.044.

### June

Liu, Kevin X., Michael G. Milligan, Jonathan D. Schoenfeld, Roy B. Tishler, Andrea K. Ng, Phillip M. Devlin, Elliott Fite, et al. 2022. "Characterization of Clinical Outcomes After Shorter Course Hypofractionated and Standard-Course Radiotherapy for Stage I-III Curatively-Treated Merkel Cell Carcinoma." Radiotherapy and Oncology 173 (August): 32--40. https://doi.org/10.1016/j.radonc.2022.05.012.

### May

Luke, Jason J, Piotr Rutkowski, Paola Queirolo, Michele Del Vecchio, Jacek Mackiewicz, Vanna Chiarion-Sileni, Luis de la Cruz Merino, et al. 2022. "Pembrolizumab Versus Placebo as Adjuvant Therapy in Completely Resected Stage IIB or IIC Melanoma (KEYNOTE-716): A Randomised, Double-Blind, Phase 3 Trial." The Lancet 399 (10336): 1718--29. https://doi.org/10.1016/s0140-6736(22)00562-1.

### April

Qian, David C, Troy Kleber, Brianna Brammer, Karen M Xu, Jeffrey M Switchenko, James R Janopaul-Naylor, Jim Zhong, et al. 2021. "Effect of Immunotherapy Time-of-Day Infusion on Overall Survival Among Patients with Advanced Melanoma in the USA (MEMOIR): A Propensity Score-Matched Analysis of a Single-Centre, Longitudinal Study." The Lancet Oncology 22 (12): 1777--86. https://doi.org/10.1016/s1470-2045(21)00546-5.

### March

McEvoy, Aubriana M., Kristina Lachance, Daniel S. Hippe, Kelsey Cahill, Yasman Moshiri, Christopher W. Lewis, Neha Singh, et al. 2022. "Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis." JAMA Dermatology 158 (4): 382. https://doi.org/10.1001/jamadermatol.2021.6096.

### February

Tawbi, Hussein A., Dirk Schadendorf, Evan J. Lipson, Paolo A. Ascierto, Luis Matamala, Erika Castillo Gutiérrez, Piotr Rutkowski, et al. 2022. "Relatlimab and Nivolumab Versus Nivolumab in Untreated Advanced Melanoma." New England Journal of Medicine 386 (1): 24--34. https://doi.org/10.1056/nejmoa2109970.

### January

Postow, Michael A., Debra A. Goldman, Alexander N. Shoushtari, Allison Betof Warner, Margaret K. Callahan, Parisa Momtaz, James W. Smithy, et al. 2022. "Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study)." Journal of Clinical Oncology40 (10): 1059--67. https://doi.org/10.1200/jco.21.01570.
:::

## 2021 Articles

::: {.callout-note appearance="minimal" collapse="true"}
## January - December 2021

### December

Harms, Paul W., Monique E. Verhaegen, Kevin Hu, Steven M. Hrycaj, May P. Chan, Chia-Jen Liu, Marina Grachtchouk, Rajiv M. Patel, Aaron M. Udager, and Andrzej A. Dlugosz. 2021. "Genomic Evidence Suggests That Cutaneous Neuroendocrine Carcinomas Can Arise from Squamous Dysplastic Precursors." Modern Pathology 35 (4): 506--14. https://doi.org/10.1038/s41379-021-00928-1.

### November

Tawbi, Hussein A, Peter A Forsyth, F Stephen Hodi, Christopher D Lao, Stergios J Moschos, Omid Hamid, Michael B Atkins, et al. 2021. "Safety and Efficacy of the Combination of Nivolumab Plus Ipilimumab in Patients with Melanoma and Asymptomatic or Symptomatic Brain Metastases (CheckMate 204)." Neuro-Oncology 23 (11): 1961--73. https://doi.org/10.1093/neuonc/noab094.

### October

Hsueh, Eddy C., James R. DeBloom, Jonathan H. Lee, Jeffrey J. Sussman, Kyle R. Covington, Hillary G. Caruso, Ann P. Quick, Robert W. Cook, Craig L. Slingluff, and Kelly M. McMasters. 2021. "Long-Term Outcomes in a Multicenter, Prospective Cohort Evaluating the Prognostic 31-Gene Expression Profile for Cutaneous Melanoma." JCO Precision Oncology, no. 5 (November): 589--601. https://doi.org/10.1200/po.20.00119.

### September

Wilmas, Kelly M., Wesley B. Garner, Matthew T. Ballo, Susan L. McGovern, and Deborah F. MacFarlane. 2021a. "The Role of Radiation Therapy in the Management of Cutaneous Malignancies. Part I: Diagnostic Modalities and Applications." Journal of the American Academy of Dermatology 85 (3): 539--48. https://doi.org/10.1016/j.jaad.2021.05.058. ---------. 2021b. "The Role of Radiation Therapy in the Management of Cutaneous Malignancies. Part II: When Is Radiation Therapy Indicated?" Journal of the American Academy of Dermatology 85 (3): 551--62. https://doi.org/10.1016/j.jaad.2021.05.057.

### August

Puebla-Tornero, Laura, Luis Antonio Corchete-Sánchez, Alberto Conde-Ferreirós, Natalia García-Sancha, Roberto Corchado-Cobos, Concepción Román-Curto, and Javier Cañueto. 2021. "Performance of Salamanca Refinement of the T3-AJCC8 Versus the Brigham and Women's Hospital and Tübingen Alternative Staging Systems for High-Risk Cutaneous Squamous Cell Carcinoma." Journal of the American Academy of Dermatology 84 (4): 938--45. https://doi.org/10.1016/j.jaad.2020.12.020.

### July

Farberg, Aaron S., Mary A. Hall, Leah Douglas, Kyle R. Covington, Sarah J. Kurley, Robert W. Cook, and Scott M. Dinehart. 2020. "Integrating Gene Expression Profiling into NCCN High-Risk Cutaneous Squamous Cell Carcinoma Management Recommendations: Impact on Patient Management." Current Medical Research and Opinion 36 (8): 1301--7. https://doi.org/10.1080/03007995.2020.1763284.

### June

Stratigos, Alexander J, Aleksandar Sekulic, Ketty Peris, Oliver Bechter, Sorilla Prey, Martin Kaatz, Karl D Lewis, et al. 2021. "Cemiplimab in Locally Advanced Basal Cell Carcinoma After Hedgehog Inhibitor Therapy: An Open-Label, Multi-Centre, Single-Arm, Phase 2 Trial." The Lancet Oncology 22 (6): 848--57. https://doi.org/10.1016/s1470-2045(21)00126-1.

### May

Andruska, Neal, Benjamin W. Fischer-Valuck, Lily Mahapatra, Randall J. Brenneman, Hiram A. Gay, Wade L. Thorstad, Ryan C. Fields, Kelly M. MacArthur, and Brian C. Baumann. 2021. "Association Between Surgical Margins Larger Than 1 Cm and Overall Survival in Patients With Merkel Cell Carcinoma." JAMA Dermatology 157 (5): 540. https://doi.org/10.1001/jamadermatol.2021.0247.

### April

Cho, Hyunje G., Karen Y. Kuo, Shufeng Li, Irene Bailey, Sumaira Aasi, Anne Lynn S. Chang, Anthony E. Oro, Jean Y. Tang, and Kavita Y. Sarin. 2018. "Frequent Basal Cell Cancer Development Is a Clinical Marker for Inherited Cancer Susceptibility." JCI Insight 3 (15). https://doi.org/10.1172/jci.insight.122744.

### March

Morgan, Frederick C., Emily Stamell Ruiz, Pritesh S. Karia, Robert J. Besaw, Victor A. Neel, and Chrysalyne D. Schmults. 2021. "Brigham and Women's Hospital Tumor Classification System for Basal Cell Carcinoma Identifies Patients with Risk of Metastasis and Death." Journal of the American Academy of Dermatology 85 (3): 582--87. https://doi.org/10.1016/j.jaad.2021.01.052.

### February

Morgan, Frederick C., Emily Stamell Ruiz, Pritesh S. Karia, Robert J. Besaw, Victor A. Neel, and Chrysalyne D. Schmults. 2020. "Factors Predictive of Recurrence, Metastasis, and Death from Primary Basal Cell Carcinoma 2 Cm or Larger in Diameter." Journal of the American Academy of Dermatology 83 (3): 832--38.

### January

Danesh, Melissa J., Tyler D. Menge, Lydia Helliwell, Meera Mahalingam, and Abigail Waldman. 2020. "Adherence to the National Comprehensive Cancer Network Criteria of Complete Circumferential Peripheral and Deep Margin Assessment in Treatment of High-Risk Basal and Squamous Cell Carcinoma." Dermatologic Surgery 46 (12): 1473--80. https://doi.org/10.1097/dss.0000000000002354.
:::

## 2020 Articles

::: {.callout-note appearance="minimal" collapse="true"}
## January - December 2020

### December

Tarabadkar, Erica S., Teresa Fu, Kristina Lachance, Daniel S. Hippe, Thomas Pulliam, Hannah Thomas, Janet Y. Li, et al. 2021. "Narrow Excision Margins Are Appropriate for Merkel Cell Carcinoma When Combined with Adjuvant Radiation: Analysis of 188 Cases of Localized Disease and Proposed Management Algorithm." Journal of the American Academy of Dermatology 84 (2): 340--47. https://doi.org/10.1016/j.jaad.2020.07.079.

### November

Owen, Joshua L, Nour Kibbi, Brandon Worley, Ryan C Kelm, Jordan V Wang, Christopher A Barker, Ramona Behshad, et al. 2019. "Sebaceous Carcinoma: Evidence-Based Clinical Practice Guidelines." The Lancet Oncology 20 (12): e699--714. https://doi.org/10.1016/s1470-2045(19)30673-4.

### October

Singh, Neha, Nora A. Alexander, Kristina Lachance, Christopher W. Lewis, Aubriana McEvoy, Gensuke Akaike, David Byrd, et al. 2021. "Clinical Benefit of Baseline Imaging in Merkel Cell Carcinoma: Analysis of 584 Patients." Journal of the American Academy of Dermatology 84 (2): 330--39. https://doi.org/10.1016/j.jaad.2020.07.065.

### September

D'Arcy, Monica E, David Castenson, Charles F Lynch, Amy R Kahn, Lindsay M Morton, Meredith S Shiels, Ruth M Pfeiffer, and Eric A Engels. 2020. "Risk of Rare Cancers Among Solid Organ Transplant Recipients." *JNCI: Journal of the National Cancer Institute*, May. <https://doi.org/10.1093/jnci/djaa078>.

### August

Schauder, David M., Jinwan Kim, and Rajiv I. Nijhawan. 2020. "Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma." JAMA Dermatology 156 (10): 1117. https://doi.org/10.1001/jamadermatol.2020.2327.

### July

Lobl, Marissa B., Dillon Clarey, Shauna Higgins, Adam Sutton, Laura Hansen, and Ashley Wysong. 2020. "Targeted Next-Generation Sequencing of Matched Localized and Metastatic Primary High-Risk SCCs Identifies Driver and Co-Occurring Mutations and Novel Therapeutic Targets." Journal of Dermatological Science 99 (1): 30--43. https://doi.org/10.1016/j.jdermsci.2020.05.007.

### June

Wysong, Ashley, Jason G. Newman, Kyle R. Covington, Sarah J. Kurley, Sherrif F. Ibrahim, Aaron S. Farberg, Anna Bar, et al. 2021. "Validation of a 40-Gene Expression Profile Test to Predict Metastatic Risk in Localized High-Risk Cutaneous Squamous Cell Carcinoma." Journal of the American Academy of Dermatology 84 (2): 361--69. https://doi.org/10.1016/j.jaad.2020.04.088.

### May

Topalian, Suzanne L., Shailender Bhatia, Asim Amin, Ragini R. Kudchadkar, William H. Sharfman, Celeste Lebbé, Jean-Pierre Delord, et al. 2020. "Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial." Journal of Clinical Oncology 38 (22): 2476--87. https://doi.org/10.1200/jco.20.00201.

### March

Sekulic, Aleksandar, Michael R. Migden, Nicole Basset-Seguin, Claus Garbe, Anja Gesierich, Christopher D. Lao, Chris Miller, et al. 2017. "Long-Term Safety and Efficacy of Vismodegib in Patients with Advanced Basal Cell Carcinoma: Final Update of the Pivotal ERIVANCE BCC Study." BMC Cancer 17 (1). https://doi.org/10.1186/s12885-017-3286-5.

### February

Ruiz, Emily Stamell, Shlomo A. Koyfman, Syril Keena T. Que, Jason Kass, and Chrysalyne D. Schmults. 2020. "Evaluation of the Utility of Localized Adjuvant Radiation for Node-Negative Primary Cutaneous Squamous Cell Carcinoma with Clear Histologic Margins." Journal of the American Academy of Dermatology 82 (2): 420--29. https://doi.org/10.1016/j.jaad.2019.07.048.

### 
:::

## 2019 Articles

::: {.callout-note appearance="minimal" collapse="true"}
## April - December 2019

### December

Knepper, Todd C., Meagan Montesion, Jeffery S. Russell, Ethan S. Sokol, Garrett M. Frampton, Vincent A. Miller, Lee A. Albacker, et al. 2019. "The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy." Clinical Cancer Research 25 (19): 5961--71. https://doi.org/10.1158/1078-0432.ccr-18-4159.

### November

Harris, Brianna N., Patrik Pipkorn, Ky Nam Bai Nguyen, Ryan S. Jackson, Shyam Rao, Michael G. Moore, D. Gregory Farwell, and Arnaud F. Bewley. 2019. "Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck." JAMA OtolaryngologyHead & Neck Surgery145 (2): 153. https://doi.org/10.1001/jamaoto.2018.3650.

Strassen, Ulrich, Benedikt Hofauer, Christian Jacobi, and Andreas Knopf. 2016. "Management of Locoregional Recurrence in Cutaneous Squamous Cell Carcinoma of the Head and Neck." European Archives of Oto-Rhino-Laryngology 274 (1): 501--6. https://doi.org/10.1007/s00405-016-4243-7.

### October

Migden, Michael R., Danny Rischin, Chrysalyne D. Schmults, Alexander Guminski, Axel Hauschild, Karl D. Lewis, Christine H. Chung, et al. 2018. "PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma." New England Journal of Medicine 379 (4): 341--51. https://doi.org/10.1056/nejmoa1805131.

### September

Fox, Matthew, Marc Brown, Nicholas Golda, Dori Goldberg, Christopher Miller, Melissa Pugliano-Mauro, Chrysalyne Schmults, et al. 2019. "Nodal Staging of High-Risk Cutaneous Squamous Cell Carcinoma." Journal of the American Academy of Dermatology 81 (2): 548--57. https://doi.org/10.1016/j.jaad.2018.09.006.

### August

Ruiz, Emily Stamell, Pritesh S. Karia, Robert Besaw, and Chrysalyne D. Schmults. 2019. "Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition Vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma." JAMA Dermatology 155 (7): 819. https://doi.org/10.1001/jamadermatol.2019.0032.

### July

Gore, Sinclair M., Douglas Shaw, Richard C. W. Martin, Wendy Kelder, Kathryn Roth, Roger Uren, Kan Gao, et al. 2015. "Prospective Study of Sentinel Node Biopsy for High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck." Head & Neck 38 (S1): E884--89. https://doi.org/10.1002/hed.24120.

### June

Miller, Natalie J., Candice D. Church, Steven P. Fling, Rima Kulikauskas, Nirasha Ramchurren, Michi M. Shinohara, Harriet M. Kluger, et al. 2018. "Merkel Cell Polyomavirus-Specific Immune Responses in Patients with Merkel Cell Carcinoma Receiving Anti-PD-1 Therapy." Journal for ImmunoTherapy of Cancer 6 (1). https://doi.org/10.1186/s40425-018-0450-7.

### May

Rosenberg, Abby R., Mary Tabacchi, Kenneth H. Ngo, Michael Wallendorf, Ilana S. Rosman, Lynn A. Cornelius, and Shadmehr Demehri. 2019. "Skin Cancer Precursor Immunotherapy for Squamous Cell Carcinoma Prevention." JCI Insight 4 (6). https://doi.org/10.1172/jci.insight.125476.

### April

Porceddu, Sandro Virgilio, Mathias Bressel, Michael Geoffrey Poulsen, Adam Stoneley, Michael John Veness, Lizbeth Moira Kenny, Chris Wratten, et al. 2018. "Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial." Journal of Clinical Oncology 36 (13): 1275--83. https://doi.org/10.1200/jco.2017.77.0941.

### 
:::
